Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor
Most CwCF on ADHD medication underwent changes in dosing and/or medication after ETI initiation. Several children were diagnosed with ADHD after starting ETI. The role of ETI in these recent diagnoses and treatment plans is unclear. Given the prevalence of pediatric ADHD diagnoses and the medication changes that were needed by this population, additional research is warranted to clarify the relationship between ETI and ADHD in CwCF.
Authors
- Mary Lynn Dell
- Anne M. May (ORCID: https://orcid.org/0000-0003-0643-3790)
- Kimberly Pasley (ORCID: https://orcid.org/0000-0003-4602-4107)
Institutions
- Hartford Hospital (US)
- Nationwide Children's Hospital (US)
- University of Connecticut (US)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1002/ppul.27246
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00